{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:17:55Z","timestamp":1784557075173,"version":"3.55.0"},"reference-count":20,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010370","name":"Harris Manchester College, University of Oxford","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010370","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>\n                      The case report outlines a 33-year-old woman with neurofibromatosis type 1 (NF1) presenting complex symptomatology including a cervical mass, bone pain and significantly elevated calcium and parathyroid hormone levels, indicative of parathyroid carcinoma accompanied by cystic fibrous osteitis. Intriguingly, an incidental finding of an adrenal nodule prompted investigation, leading to the diagnosis of pheochromocytoma. Surgical intervention confirmed the presence of pheochromocytoma and parathyroid carcinoma. Genetic analysis corroborated NF1 with a pathogenic variant in the\n                      <jats:italic>NF1<\/jats:italic>\n                      gene. The patient\u2019s clinical manifestations, coupled with the presence of caf\u00e9-au-lait spots and axillary freckles, supported the diagnosis of NF1. This case not only highlights the challenging diagnostic landscape of NF1 but also underscores the rarity of the co-occurrence of parathyroid carcinoma and pheochromocytoma within the context of NF1. It emphasizes the necessity for heightened clinical suspicion and comprehensive evaluation in patients with NF1, particularly in those presenting with endocrine abnormalities. Further investigation into the underlying mechanisms linking these conditions is warranted to elucidate their pathophysiological interplay and inform optimal therapeutic strategies for affected individuals. This case underscores the importance of multidisciplinary collaboration in the management of complex NF1-associated manifestations, with an emphasis on early detection and tailored intervention to optimize patient outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Learning points<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>Rare but real: multiple endocrine tumors can coexist in patients with neurofibromatosis type 1 (NF1), not only pheochromocytoma.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Early detection matters: prompt diagnosis and a multidisciplinary approach are crucial for managing NF1 patients presenting with symptoms suggestive of these rare endocrine tumors.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Genetic insights guide care: genetic testing aids in confirming NF1 and guiding treatment decisions, emphasizing the role of genetics in personalized medicine for NF1 patients.<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>","DOI":"10.1530\/edm-24-0077","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T06:44:49Z","timestamp":1739256289000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":0,"title":["Parathyroid carcinoma and pheochromocytoma in a patient with neurofibromatosis type 1: a rare association"],"prefix":"10.1530","volume":"2025","author":[{"given":"Jardelina Brena Rocha","family":"Leite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Ramalho","family":"De Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaella Nelice de Holanda","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Trov\u00e3o Diniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8474-408X","authenticated-orcid":true,"given":"Gabriel Rodrigues de Assis","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fern\u00e3o Henrique","family":"Costa e Alvim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Ribeiro Coutinho","family":"Madruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Th\u00e9","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Sampaio","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruy","family":"Lyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Vilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Ann Saudi Med","first-page":"255","article-title":"Parathyroid adenoma and bilateral pheochromocytoma in a patient with neurofibromatosis","volume":"25","author":"Al-Wahhabi B","year":"2005","unstructured":"Al-Wahhabi B\n\n. Parathyroid adenoma and bilateral pheochromocytoma in a patient with neurofibromatosis. Ann Saudi Med 2005 25 255\u2013257. (https:\/\/doi.org\/10.5144\/0256-4947.2005.255)"},{"key":"bib2","series-title":"Cancer","first-page":"2125","article-title":"Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population","volume":"79","author":"Z\u00f6ller MET","year":"1997","unstructured":"Z\u00f6ller MET\n, \nRembeck B\n, \nOd\u00f6n A\n, et al.\n Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer 1997 79 2125\u20132131. (https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19970601)79:11<2125::AID-CNCR9>3.0.CO;2-N)"},{"key":"bib3","series-title":"J Endocr Soc","first-page":"bvad083","article-title":"Prevalence of endocrine manifestations and GIST in 108 systematically screened patients with neurofibromatosis type 1","volume":"7","author":"Dupuis H","year":"2023","unstructured":"Dupuis H\n, \nChevalier B\n, \nCardot-Bauters C\n, et al.\n Prevalence of endocrine manifestations and GIST in 108 systematically screened patients with neurofibromatosis type 1. J Endocr Soc 2023 7 bvad083. (https:\/\/doi.org\/10.1210\/jendso\/bvad083)"},{"key":"bib4","series-title":"Clin Endocrinol","first-page":"141","article-title":"Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1","volume":"86","author":"Gruber LM","year":"2017","unstructured":"Gruber LM\n, \nErickson D\n, \nBabovic-Vuksanovic D\n, et al.\n Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1. Clin Endocrinol 2017 86 141\u2013149. (https:\/\/doi.org\/10.1111\/cen.13163)"},{"key":"bib5","series-title":"Brain","first-page":"152","article-title":"Prognostic factors of CNS tumours in neurofibromatosis 1 (NF1): a retrospective study of 104 patients","volume":"126","author":"Guillamo JS","year":"2003","unstructured":"Guillamo JS\n, \nCr\u00e9ange A\n, \nKalifa C\n, et al.\n Prognostic factors of CNS tumours in neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain 2003 126 152\u2013160. (https:\/\/doi.org\/10.1093\/brain\/awg016)"},{"key":"bib6","series-title":"Plast Reconstr Surg","first-page":"34e","article-title":"Neurofibromatosis: a cause of prepubertal gynecomastia","volume":"121","author":"Cho YR","year":"2008","unstructured":"Cho YR\n, \nJones S\n & \nGosain AK\n\n. Neurofibromatosis: a cause of prepubertal gynecomastia. Plast Reconstr Surg 2008 121 34e\u201340e. (https:\/\/doi.org\/10.1097\/01.prs.0000299299.46365.7e)"},{"key":"bib7","series-title":"J Bone Miner Res","first-page":"2333","article-title":"A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age","volume":"27","author":"Heerv\u00e4 E","year":"2012","unstructured":"Heerv\u00e4 E\n, \nKoffert A\n, \nJokinen E\n, et al.\n A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age. J Bone Miner Res 2012 27 2333\u20132337. (https:\/\/doi.org\/10.1002\/jbmr.1685)"},{"key":"bib8","series-title":"Intern Med","first-page":"2451","article-title":"Neurofibromatosis type 1 with concurrent multiple endocrine disorders: adenomatous goiter, primary hyperparathyroidism, and acromegaly","volume":"60","author":"Yasuda S","year":"2021","unstructured":"Yasuda S\n, \nInoue I\n & \nShimada A\n\n. Neurofibromatosis type 1 with concurrent multiple endocrine disorders: adenomatous goiter, primary hyperparathyroidism, and acromegaly. Intern Med 2021 60 2451\u20132459. (https:\/\/doi.org\/10.2169\/internalmedicine.4981-20)"},{"key":"bib9","series-title":"Lancet Neurol","first-page":"834","article-title":"Neurofibromatosis type 1: a multidisciplinary approach to care","volume":"13","author":"Hirbe AC","year":"2014","unstructured":"Hirbe AC\n & \nGutmann DH\n\n. Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol 2014 13 834\u2013843. (https:\/\/doi.org\/10.1016\/S1474-4422(14)70063-8)"},{"key":"bib10","series-title":"Arch Endocrinol Metab","first-page":"460","article-title":"Association between atypical parathyroid adenoma and neurofibromatosis","volume":"59","author":"de Favere AMF","year":"2015","unstructured":"de Favere AMF\n, \nTsukumo DM\n, \nde Matos PS\n, et al.\n Association between atypical parathyroid adenoma and neurofibromatosis. Arch Endocrinol Metab 2015 59 460\u2013466. (https:\/\/doi.org\/10.1590\/2359-3997000000092)"},{"key":"bib11","series-title":"Front Horm Res","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000491039","article-title":"Parathyroid carcinoma","volume":"51","author":"Cetani F","unstructured":"Cetani F\n, \nPardi E\n & \nMarcocci C\n\n. Parathyroid carcinoma. Front Horm Res 51 63\u201376. (https:\/\/doi.org\/10.1159\/000491039)"},{"key":"bib12","series-title":"Curr Opin Otolaryngol Head Neck Surg","first-page":"155","article-title":"Parathyroid carcinoma","volume":"24","author":"Goswamy J","year":"2016","unstructured":"Goswamy J\n, \nLei M\n & \nSimo R\n\n. Parathyroid carcinoma. Curr Opin Otolaryngol Head Neck Surg 2016 24 155\u2013162. (https:\/\/doi.org\/10.1097\/MOO.0000000000000234)"},{"key":"bib13","series-title":"Biol Rev","first-page":"425","article-title":"Human cell type diversity, evolution, development, and classification with special reference to cells derived from the neural crest","volume":"81","author":"Vickaryous MK","year":"2006","unstructured":"Vickaryous MK\n & \nHall BK\n\n. Human cell type diversity, evolution, development, and classification with special reference to cells derived from the neural crest. Biol Rev 2006 81 425. (https:\/\/doi.org\/10.1017\/S1464793106007068)"},{"key":"bib14","series-title":"J Clin Oncol","first-page":"1978","article-title":"Distinctive cancer associations in patients with neurofibromatosis type 1","volume":"34","author":"Uusitalo E","year":"2016","unstructured":"Uusitalo E\n, \nRantanen M\n, \nKallionp\u00e4\u00e4 RA\n, et al.\n Distinctive cancer associations in patients with neurofibromatosis type 1. J Clin Oncol 2016 34 1978\u20131986. (https:\/\/doi.org\/10.1200\/JCO.2015.65.3576)"},{"key":"bib15","series-title":"Br J Cancer","first-page":"233","article-title":"A prospective study of neurofibromatosis type 1 cancer incidence in the UK","volume":"95","author":"Walker L","year":"2006","unstructured":"Walker L\n, \nThompson D\n, \nEaston D\n, et al.\n A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer 2006 95 233\u2013238. (https:\/\/doi.org\/10.1038\/sj.bjc.6603227)"},{"key":"bib16","series-title":"Endocr Metab Immune Disord Drug Targets","first-page":"382","article-title":"Parathyroid carcinoma causing mild hyperparathyroidism in neurofibromatosis type 1: a case report and systematic review","volume":"19","author":"Triggiani V","year":"2019","unstructured":"Triggiani V\n, \nCastellana M\n, \nBasile P\n, et al.\n Parathyroid carcinoma causing mild hyperparathyroidism in neurofibromatosis type 1: a case report and systematic review. Endocr Metab Immune Disord Drug Targets 2019 19 382\u2013388. (https:\/\/doi.org\/10.2174\/1871530318666180910123316)"},{"key":"bib17","series-title":"J Urol","first-page":"1582","article-title":"von Recklinghausen\u2019s disease and pheochromocytomas","volume":"162","author":"Walther MM","year":"1999","unstructured":"Walther MM\n, \nHerring J\n, \nEnquist E\n, et al.\n von Recklinghausen\u2019s disease and pheochromocytomas. J Urol 1999 162 1582\u20131586. (https:\/\/doi.org\/10.1016\/S0022-5347(05)68171-2)"},{"key":"bib18","series-title":"Arq Bras Endocrinol Metabol","first-page":"507","article-title":"Patog\u00eanese molecular do feocromocitoma","volume":"45","author":"Dahia PLM","year":"2001","unstructured":"Dahia PLM\n\n. Patog\u00eanese molecular do feocromocitoma. Arq Bras Endocrinol Metabol 2001 45 507\u2013519. (https:\/\/doi.org\/10.1590\/S0004-27302001000600003)"},{"key":"bib19","series-title":"Endocrinol Diabetes Metab Case Rep","first-page":"18-0006","article-title":"Concurrent primary hyperparathyroidism and pheochromocytoma in a Chinese lady with neurofibromatosis type 1","volume":"2018","author":"Wong C-L","year":"2018","unstructured":"Wong C-L\n, \nFok C-K\n & \nTam VH-K\n\n. Concurrent primary hyperparathyroidism and pheochromocytoma in a Chinese lady with neurofibromatosis type 1. Endocrinol Diabetes Metab Case Rep 2018 2018 18-0006. (https:\/\/doi.org\/10.1530\/edm-18-0006)"},{"key":"bib20","series-title":"Surgery","first-page":"827","article-title":"Parathyroid carcinoma and neurofibromatosis","volume":"144","author":"Demirjian AN","year":"2008","unstructured":"Demirjian AN\n, \nGrossman JM\n, \nChan JL\n, et al.\n Parathyroid carcinoma and neurofibromatosis. Surgery 2008 144 827\u2013829. (https:\/\/doi.org\/10.1016\/j.surg.2008.07.015)"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2025\/1\/EDM-24-0077.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2025\/1\/EDM-24-0077.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2025\/1\/EDM-24-0077.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:48:28Z","timestamp":1784555308000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":20,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1530\/edm-24-0077","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]}}}